Literature DB >> 10823122

Postmortem findings after fatal anaphylactic reactions.

R S Pumphrey1, I S Roberts.   

Abstract

AIMS: To determine the frequency at which classic manifestations of anaphylaxis are present at necropsy after fatal anaphylactic reactions.
METHODS: A register has been established of fatal anaphylactic reactions in the UK since 1992, traced from the certified cause of death and other sources. Details of the previous medical history and the reaction suggest anaphylaxis as the cause of death for 130 cases; a postmortem report was available for 56.
RESULTS: The 56 deaths studied included 19 reactions to bee or wasp venom, 16 to foods, and 21 to drugs or contrast media. Death occurred within one hour of anaphylaxis in 39 cases. Macroscopic findings included signs of asthma (mucous plugging and/or hyper-inflated lungs) (15 of 56), petechial haemorrhages (10 of 56), pharyngeal/laryngeal oedema (23 of 56), but for 23 of 56 there was nothing indicative of an allergic death. Mast cell tryptase was raised in 14 of 16 cases tested; three of three tested had detectable IgE specific for the suspected allergen.
CONCLUSIONS: In many cases of fatal anaphylaxis no specific macroscopic findings are present at postmortem examination. This reflects the rapidity and mode of death, which is often the result of shock rather than asphyxia. Investigations that might help determine whether anaphylaxis was the cause of death had rarely been performed. In the presence of a typical clinical history, absence of postmortem findings does not exclude the diagnosis of anaphylaxis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823122      PMCID: PMC1731177          DOI: 10.1136/jcp.53.4.273

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

Review 1.  Case report of anaphylaxis from cisplatin/paclitaxel and a review of their hypersensitivity reaction profiles.

Authors:  C Ciesielski-Carlucci; P Leong; C Jacobs
Journal:  Am J Clin Oncol       Date:  1997-08       Impact factor: 2.339

2.  Fatal anaphylactic reaction to hair dye.

Authors:  A L Belton; T Chira
Journal:  Am J Forensic Med Pathol       Date:  1997-09       Impact factor: 0.921

3.  Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis.

Authors:  L B Schwartz; J W Yunginger; J Miller; R Bokhari; D Dull
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

4.  Elevated postmortem tryptase in the absence of anaphylaxis.

Authors:  B Randall; J Butts; J F Halsey
Journal:  J Forensic Sci       Date:  1995-03       Impact factor: 1.832

5.  Is unrecognized anaphylaxis a cause of sudden unexpected death?

Authors:  H J Schwartz; J W Yunginger; L B Schwartz
Journal:  Clin Exp Allergy       Date:  1995-09       Impact factor: 5.018

6.  The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis.

Authors:  L B Schwartz; K Sakai; T R Bradford; S Ren; B Zweiman; A S Worobec; D D Metcalfe
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

7.  Markers of mast cell degranulation.

Authors:  A D Hogan; L B Schwartz
Journal:  Methods       Date:  1997-09       Impact factor: 3.608

8.  Laboratory investigation of deaths due to anaphylaxis.

Authors:  J W Yunginger; D R Nelson; D L Squillace; R T Jones; K E Holley; B A Hyma; L Biedrzycki; K G Sweeney; W Q Sturner; L B Schwartz
Journal:  J Forensic Sci       Date:  1991-05       Impact factor: 1.832

9.  Postmortem serum levels of tryptase and total and specific IgE in fatal asthma.

Authors:  M L Salkie; I Mitchell; C W Revers; A Karkhanis; J Butt; S Tough; F H Green
Journal:  Allergy Asthma Proc       Date:  1998 May-Jun       Impact factor: 2.587

10.  Fatal anaphylaxis due to fire ant stings.

Authors:  J A Prahlow; J J Barnard
Journal:  Am J Forensic Med Pathol       Date:  1998-06       Impact factor: 0.921

View more
  50 in total

1.  Food allergy in childhood.

Authors:  A T Clark; P W Ewan
Journal:  Arch Dis Child       Date:  2003-01       Impact factor: 3.791

Review 2.  Postmortem chemistry update part II.

Authors:  Cristian Palmiere; Patrice Mangin
Journal:  Int J Legal Med       Date:  2011-10-09       Impact factor: 2.686

3.  Anaphylaxis as an adverse event following immunisation.

Authors:  Michel Erlewyn-Lajeunesse; Jan Bonhoeffer; Jens U Ruggeberg; Paul T Heath
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

4.  Postmortem serum levels of total IgE.

Authors:  Lara Tran; Cristian Palmiere
Journal:  Int J Legal Med       Date:  2016-06-09       Impact factor: 2.686

5.  Is a positive history of non-anaesthetic drug allergy a predictive factor for positive allergy tests to anaesthetics?

Authors:  Natalia Hagau; Nadia Gherman-Ionica; Denisa Hagau; Sebastian Tranca; Manuela Sfichi; Dan Longrois
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

Review 6.  Sudden death by laryngeal polyp: a case report and review of the literature.

Authors:  Jeff Tanguay; Michael Pollanen
Journal:  Forensic Sci Med Pathol       Date:  2008-09-25       Impact factor: 2.007

7.  Adrenaline in the Acute Treatment of Anaphylaxis.

Authors:  Johannes Ring; Ludger Klimek; Margitta Worm
Journal:  Dtsch Arztebl Int       Date:  2018-08-06       Impact factor: 5.594

8.  Death in anaphylaxis in a man with house dust mite allergy.

Authors:  Erik Edston; Marianne van Hage-Hamsten
Journal:  Int J Legal Med       Date:  2003-07-03       Impact factor: 2.686

9.  Two Cases of Rocuronium-Induced Anaphylaxis/Anaphylactic Shock Successfully Treated With Sugammadex.

Authors:  Mayumi Hashimoto; Aiji Sato Boku; Naoko Tachi; Yoko Okumura; Kanenori Kadoi; Jun Harada; Masahiro Okuda
Journal:  Anesth Prog       Date:  2019

10.  Survey of the use of epinephrine (adrenaline) for anaphylaxis by junior hospital doctors.

Authors:  Ricardo Jose; Gerald J Clesham
Journal:  Postgrad Med J       Date:  2007-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.